Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
1 this month

Showing 5141–5160 of 17,529 recalls

December 17, 2020· CIPLA

Recalled Item: Esomeprazole Magnesium for Delayed-Release Oral Suspension 10mg

The Issue: Cross- contamination with other products: The excipient, Crospovidone,

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
December 16, 2020· US Compounding Inc

Recalled Item: Succinylcholine Chloride PF Inj. 200 mg/10 mL

The Issue: Labeling: Incorrect or Missing lot and/or expiration date:

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
December 14, 2020· SCA Pharmaceuticals, Inc.

Recalled Item: Vasopressin 20 Units added to 0.9% Sodium Chloride 100 mL Rx Only

The Issue: Subpotent drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
December 14, 2020· CIPLA

Recalled Item: Azacitidine for Injection 100 mg/vial For Subcutaneous and Intravenous Use

The Issue: cGMP deviations: Vials may not be sealed correctly

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
December 10, 2020· Fresenius Kabi USA, LLC

Recalled Item: Sensorcaine-MPF (Bupivacaine HCl and Epinephrine Injection

The Issue: Subpotent Drug: Low out-of-specification assay results for the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
December 9, 2020· Akebia Therapeutics dba Keryx Biopharmaceutials, Inc

Recalled Item: Auryxia (ferric citrate) tablets

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
December 9, 2020· Morton Grove Pharmaceuticals, Inc.

Recalled Item: Hydroxyzine Hydrochloride Oral Solution

The Issue: Failed Impurities/Degradation Specification: OOS for the following -

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
December 9, 2020· Biogen MA Inc.

Recalled Item: Vumerity (diroximel fumarate) delayed-release capsule

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
December 8, 2020· Shilpa Medicare Limited

Recalled Item: Azacitidine for Injection 100 mg/vial

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
December 8, 2020· Shilpa Medicare Limited

Recalled Item: Imatinib Mesylate Tablets 400 mg

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
December 8, 2020· Shilpa Medicare Limited

Recalled Item: Azacitidine for Injection 100 mg/vial

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
December 8, 2020· Shilpa Medicare Limited

Recalled Item: Docetaxel Injection USP 160 mg/8mL (20 mg/mL)

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
December 8, 2020· Shilpa Medicare Limited

Recalled Item: Busulfan Injection 60 mg/10 mL (6 mg/mL)

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
December 8, 2020· Shilpa Medicare Limited

Recalled Item: Imatinib Mesylate Tablets 100 mg

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
December 7, 2020· AVKARE Inc.

Recalled Item: TraZODONE Hydrochloride Tablets USP 100 mg

The Issue: Product mix-up: Bottles of sildenafil and trazodone were

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
December 7, 2020· AVKARE Inc.

Recalled Item: Sildenafil Tablets USP 100 mg

The Issue: Product mix-up: Bottles of sildenafil and trazodone were

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
December 7, 2020· Hikma Pharmaceuticals USA Inc.

Recalled Item: Sodium Chloride Injection

The Issue: Failed pH Specifications: Out of Specification pH Test

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
December 3, 2020· Zydus Pharmaceuticals (USA) Inc

Recalled Item: Lansoprazole Delayed-Release Orally Disintegrating Tablets 15 mg

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
December 3, 2020· Zydus Pharmaceuticals (USA) Inc

Recalled Item: Lansoprazole Delayed-Release Orally Disintegrating Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
December 1, 2020· GAZA PROVEEDORA DE SERVICIOS DE HOSPEDAJE Y ALIMENTACION

Recalled Item: Zapien Productos Hand Sanitizer Gel Antibacterial

The Issue: cGMP deviations: Product made at the same facility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund